R01 MH084888/MH/NIMH NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2011	4
2012	2
2013	1
2014	3
2015	2
2019	1
2021	1
2022	2
2024	0

1

Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Sharma H, Santra S, Dutta A. Sharma H, et al. Future Med Chem. 2015;7(17):2385-406. doi: 10.4155/fmc.15.134. Epub 2015 Nov 30. Future Med Chem. 2015. PMID: 26619226 Free PMC article. Review.

2

Novel Potent Dopamine-Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters.

Santra S, Kortagere S, Vedachalam S, Gogoi S, Antonio T, Reith MEA, Dutta AK. Santra S, et al. ACS Chem Neurosci. 2021 Apr 21;12(8):1406-1418. doi: 10.1021/acschemneuro.1c00078. Epub 2021 Apr 12. ACS Chem Neurosci. 2021. PMID: 33844493

3

Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.

Santra S, Sharma H, Vedachalam S, Antonio T, Reith M, Dutta A. Santra S, et al. Bioorg Med Chem. 2015 Feb 15;23(4):821-8. doi: 10.1016/j.bmc.2014.12.040. Epub 2014 Dec 25. Bioorg Med Chem. 2015. PMID: 25593099 Free PMC article.

4

Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants.

Santra S, Gogoi S, Gopishetty B, Antonio T, Zhen J, Reith ME, Dutta AK. Santra S, et al. ChemMedChem. 2012 Dec;7(12):2093-100. doi: 10.1002/cmdc.201200352. Epub 2012 Oct 11. ChemMedChem. 2012. PMID: 23060293 Free PMC article.

5

D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.

Dutta AK, Santra S, Harutyunyan A, Das B, Lisieski MJ, Xu L, Antonio T, Reith MEA, Perrine SA. Dutta AK, et al. Eur J Pharmacol. 2019 Nov 5;862:172632. doi: 10.1016/j.ejphar.2019.172632. Epub 2019 Aug 29. Eur J Pharmacol. 2019. PMID: 31473161 Free PMC article.

6

Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.

Gopishetty B, Hazeldine S, Santra S, Johnson M, Modi G, Ali S, Zhen J, Reith M, Dutta A. Gopishetty B, et al. J Med Chem. 2011 Apr 28;54(8):2924-32. doi: 10.1021/jm200020a. Epub 2011 Mar 29. J Med Chem. 2011. PMID: 21446715 Free PMC article.

7

Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632].

Dutta AK, Santra S, Harutyunyan A, Das B, Lisieski MJ, Xu L, Antonio T, Reith MEA, Perrine SA. Dutta AK, et al. Eur J Pharmacol. 2022 Oct 15;933:175286. doi: 10.1016/j.ejphar.2022.175286. Epub 2022 Sep 24. Eur J Pharmacol. 2022. PMID: 36167739 Free PMC article. No abstract available.

8

Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.

Sharma H, Santra S, Debnath J, Antonio T, Reith M, Dutta A. Sharma H, et al. Bioorg Med Chem. 2014 Jan 1;22(1):311-24. doi: 10.1016/j.bmc.2013.11.017. Epub 2013 Nov 19. Bioorg Med Chem. 2014. PMID: 24315194 Free PMC article.

9

Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.

Dutta AK, Santra S, Sharma H, Voshavar C, Xu L, Mabrouk O, Antonio T, Reith ME. Dutta AK, et al. PLoS One. 2014 Nov 26;9(11):e113420. doi: 10.1371/journal.pone.0113420. eCollection 2014. PLoS One. 2014. PMID: 25427177 Free PMC article.

10

Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640].

Dutta AK, Santra S, Harutyunyan A, Das B, Lisieski MJ, Xu L, Antonio T, Reith MEA, Perrine SA. Dutta AK, et al. Eur J Pharmacol. 2022 Sep 15;931:175232. doi: 10.1016/j.ejphar.2022.175232. Epub 2022 Aug 26. Eur J Pharmacol. 2022. PMID: 36038378 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year